Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

positive   crawled date : 2021 - 04 - 12    save search

Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines
Published: 2021-04-12 (Crawled : 20:00) - biospace.com/
APDN | $0.3396 0.59% 0.59% 85K twitter stocktwits trandingview |
Commercial Services
| | O: -0.42% H: 10.47% C: -6.22%

covid positive results vaccine trial
APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial
Published: 2021-04-12 (Crawled : 18:00) - adnas.com
APDN | $0.3396 0.59% 0.59% 85K twitter stocktwits trandingview |
Commercial Services
| | O: -0.42% H: 10.47% C: -6.22%

positive results trial
Bit Digital Announces North American Executive Team Headquartered in New York, Positions for Rapid Growth
Published: 2021-04-12 (Crawled : 13:00) - prnewswire.com
BTBT | $1.975 2.33% 2.28% 5.1M twitter stocktwits trandingview |
Finance
| | O: 2.59% H: 3.28% C: -12.64%

growth positive
Genprex Collaborators Report Positive Preclinical Data for REQORSA™ Immunogene Therapy in Non-Small Cell Lung Cancer at the 2021 AACR Annual Meeting
Published: 2021-04-12 (Crawled : 13:00) - biospace.com/
GNPX | $2.2194 -2.31% 38K twitter stocktwits trandingview |
Health Technology
| | O: 1.57% H: 5.08% C: -6.62%

lung cancer gene therapy positive therapy cancer collaboration preclinical pre-clinical
Kiniksa Announces Positive Results for Mavrilimumab Phase 2 Trial in Non-Mechanically Ventilated Severe COVID-19 Patients
Published: 2021-04-12 (Crawled : 13:00) - biospace.com/
KNSA | $16.93 0.3% 0.3% 380K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.11% C: -8.71%

covid phase 2 positive results positive results trial
Rubius Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of RTX-321 for the Treatment of HPV 16-Positive Cancers
Published: 2021-04-12 (Crawled : 12:15) - globenewswire.com
RUBY | $0.057 -99.3% 760K twitter stocktwits trandingview |
Health Technology
| | O: -1.68% H: 2.54% C: -5.2%

treatment phase 1 positive cancer trial rtx-321 phase 3 phase 2
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.